We are live on ! Find out more
ESLAW icon

Estrella Immunopharma Warrant
ESLAW

18 hedge funds and large institutions have $2.25M invested in Estrella Immunopharma Warrant in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

13% more funds holding

Funds holding: 16 → 18 (+2)

15% less capital invested

Capital invested by funds: $2.64M → $2.25M (-$395K)

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
2
Closed
–
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
SOA
Sea Otter Advisors
Florida
+$2.61K
2
RCM
Robinson Capital Management
Michigan
+$771
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$118
4
Bank of America
Bank of America
North Carolina
+$7
5
CS
Clear Street
New York
+$7

Top Sellers

Rank Fund Capital Flow
1
KPF
K2 Principal Fund
Ontario, Canada
-$994
2
CH
CVI Holdings
Delaware
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$2.14M – – –
ASM
2
ATW SPAC Management
New York
$21.6K – – –
EFI
3
EHP Funds Inc
Canada
$17K – – –
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$12.1K – – –
CH
5
CVI Holdings
Delaware
$8.81K -$1 -20 -0%
KPF
6
K2 Principal Fund
Ontario, Canada
$8.6K -$994 -15,219 -11%
Hudson Bay Capital Management
7
Hudson Bay Capital Management
Connecticut
$7.16K – – –
YCM
8
Yakira Capital Management
Connecticut
$6.59K – – –
SIA
9
SkyView Investment Advisors
New Jersey
$6K – – –
RCM
10
Radcliffe Capital Management
Pennsylvania
$4.93K – – –
WA
11
Whitebox Advisors
Minnesota
$4.65K – – –
SOA
12
Sea Otter Advisors
Florida
$4.09K +$2.61K +40,000 New
CS
13
Clear Street
New York
$2.83K +$7 +100 +0.4%
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$2.49K +$118 +1,809 +8%
SSA
15
Schonfeld Strategic Advisors
New York
$1.92K – – –
LCM
16
Landscape Capital Management
New Jersey
$1.4K – – –
RCM
17
Robinson Capital Management
Michigan
$1.03K +$771 +11,805 New
Bank of America
18
Bank of America
North Carolina
$29 +$7 +100 +33%

ESLAW Hedge Fund Activity: Q1 2023 in Review

18 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma Warrant (ESLAW) for Q1 2023, worth a combined $2.25M — down 15% from $2.64M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ESLAW positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Sea Otter Advisors, opening a new position worth an estimated $2.61K. The largest seller was K2 Principal Fund, cutting an estimated $994.

  • 18 institutional investors held Estrella Immunopharma Warrant (ESLAW) as of Q1 2023, up from 16 in Q4 2022.
  • Funds reported $2.25M of Estrella Immunopharma Warrant stock for Q1 2023, down 15% quarter-over-quarter.
  • 2 funds opened new Estrella Immunopharma Warrant positions in Q1 2023 and 0 closed out, a net change of +2 holders.
  • The largest Estrella Immunopharma Warrant buyer in Q1 2023 was Sea Otter Advisors, an estimated $2.61K added.
  • The largest Estrella Immunopharma Warrant seller in Q1 2023 was K2 Principal Fund, an estimated $994 sold.

Based on aggregated 13F filings for Q1 2023.